Innovative gene therapy treatment may extend life expectancy for epilepsy patients
中文版请点击此处
Use the fields below to perform an advanced search of The Cavalier Daily's archives. This will return articles, images, and multimedia relevant to your query. You can also try a Basic search
4 items found for your search. If no results were found please broaden your search.
中文版请点击此处
A recent discovery by researchers in the School of Medicine suggests a potential new target for osteoporosis and bone loss from rheumatoid arthritis. These findings explain why bone cells called osteoclasts tend to break down more bone than the body can replace.
In a multi-center study led by Asst. Medicine Prof. Heather Ferris, researchers found cholesterol produced by brain cells called astrocytes leads to beta-amyloid production, which results in the accumulation of plaques within the brain. The study suggests blocking cholesterol production by targeting astrocytes in a lab model of Alzheimer’s disease shows a decrease in beta-amyloid production, meaning less buildup of plaque in the brain.
Researchers at the University’s Brain Immunology and Glia Center have recently discovered a natural brain repair mechanism may improve current epilepsy treatments.